Advertisement

Topics

Developing new molecular methods for synthetizing treatments for drug-resistant cancers

19:00 EST 14 Nov 2017 | AAAS

(Worcester Polytechnic Institute) With a $1.7 million award from the National Institutes of Health (NIH), Anita Mattson, a biochemist at Worcester Polytechnic Institute (WPI), will develop a new class of catalysts that could make it possible to reliably synthesize organic compounds that hold the promise of treating cancers that have become resistant to commonly used chemotherapy medications. The catalysts may also open the door to a new approach to discovering new drugs for cancer and many other diseases.

Original Article: Developing new molecular methods for synthetizing treatments for drug-resistant cancers

NEXT ARTICLE

More From BioPortfolio on "Developing new molecular methods for synthetizing treatments for drug-resistant cancers"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...